Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The annual report by Sir Donald Acheson on the State of the Public Health for the year 1983 included more detailed information regarding AIDS than the previous year.

Published on: 24 September, 2024

The annual report by Sir Donald Acheson on the State of the Public Health for the year 1985 addressed AIDS. There was no section on hepatitis.

Published on: 24 September, 2024

The annual report by Sir Donald Acheson on the State of the Public Health for the year 1986 noted that cases of and deaths from AIDS showed exponential growth. There was no section on hepatitis.

Published on: 24 September, 2024

The annual report by Sir Donald Acheson on the State of the Public Health for the year 1987 addressed AIDS in the introduction with a focus on international cooperation. There was no section on hepatitis.

Published on: 24 September, 2024

The annual report by Sir Donald Acheson on the State of the Public Health for the year 1988 addressed AIDS in the introduction. There was no section on hepatitis.

Published on: 24 September, 2024

In a letter from A J Beale Solicitors to Jayant Desai related to the HIV litigation, the Welsh Office described relying on the Department of Health "to take the principal lead in determining national policy on matters relating to HIV/AIDS prevention, but contributes to the formulation of policy through membership of Inter-Departmental bodies and their sub-groups".

Published on: 24 September, 2024

The Welsh office formed an AIDS Steering Group.

Published on: 24 September, 2024

The Welsh office issued a recommendation to all Welsh district health authorities to set up AIDS Co-ordinating teams.

Published on: 24 September, 2024

An appendix to a letter from A J Beale Solicitors to Jayant Desai set out the legal framework of the health service in Wales.

Published on: 24 September, 2024

J Evans wrote to Jayant Desai regarding the haemophilia/HIV litigation, indicating that there was no independent Welsh Office action concerning the hepatitis risk.

Published on: 24 September, 2024

The Welsh Office first considered the risk of infection from AIDS following a briefing provided by the DHSS.

Published on: 24 September, 2024

Discussions took place between the Health Ministers of Northern Ireland and the Republic of Ireland regarding a public education campaign and measures to limit the spread of HIV.

Published on: 24 September, 2024

The Department of Health sought further advice from the Advisory Group on Testing for the Presence of Australia Hepatitis Associated Antigen and its Antibody on their report produced in July 1971 following consultations with a number of interested bodies and organisations.

Published on: 24 September, 2024

Minutes of a meeting of the Advisory Committee on Dangerous Pathogens show that the terms of reference of a Working Group focusing on the handling of material from AIDS patients did not include blood products because "the Blood Transfusion Service AIDS Working Party had a study of blood products well under way" and "the Committee was not equipped to do a detailed study of blood products since members did not have the know-how."

Published on: 24 September, 2024

At a meeting of the Advisory Committee on Dangerous Pathogens, the Chair explained that NANBH viruses "had a more serious effect than hepatitis A, in fact nearly as serious as Hepatitis B".

Published on: 24 September, 2024

At a meeting of the Advisory Committee on Dangerous Pathogens, it was noted that both DHSS and HSE "would like some guidance from ACDP and hopefully a Working Group set up to look into, and report on" the problem of handling cases/suspected cases of AIDS.

Published on: 24 September, 2024

A first report of the Advisory Group on Testing for Australia (Hepatitis - Associated) Antigen and its Antibody was produced.

Published on: 24 September, 2024

The second report of the Advisory Group on Testing for the presence of Hepatitis B surface antigen recommended a change in the method of testing for HBsAg .

Published on: 24 September, 2024

A report prepared for a meeting of RTDs observed there was a higher incidence of antigenaemia among donors who are inmates than among other donors.

Published on: 24 September, 2024

The first "Dear Doctor" letter regarding AIDS was issued to all doctors in England providing general information and advising doctors to bear the diagnosis in mind.

Published on: 24 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2165
  • Page 2166
  • Page 2167
  • Page 2168
  • Current page 2169
  • Page 2170
  • Page 2171
  • Page 2172
  • Page 2173
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.